Story thread · 2 reports / 2 sources
Kyverna says long-term data bolster FDA submission for rare autoimmune CAR-T
endpts.com · 3h · first report
Kyverna Therapeutics touted positive one-year results on Thursday in patients with a rare autoimmune disorder called stiff person syndrome. The condition affects about 6,000 patients in the US, causing painful muscle spasms and stiffness. Kyverna’s ...
The coverage
- Kyverna reports one-year data for autoimmune CAR T therapy
investing.com · 3h
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.